Skip to main content
Premium Trial:

Request an Annual Quote

IncellDx, Celsee Diagnostics Partner on Cancer Immunotherapy Research

NEW YORK (GenomeWeb) – IncellDx and Celsee Diagnostics announced today that they have partnered to test the combination of their respective protein expression analysis and rare cell isolation technologies for predicting patient responses to metastatic lung cancer immunotherapy.

Under the terms of the deal, the companies will perform IncellDx's OncoTect iO quantitative assay for PD-L1 expression on peripheral blood samples obtained from metastatic lung cancer patients using Celsee's single-cell isolation and analysis platforms. The results will then be compared with OncoTect iO data from primary tumors tissue dissociated with IncellDx's IncellPrep kit. This analysis will be used to tailor cancer therapy to more closely address clones capable of spreading, and could potentially be used with additional cancer types, the companies said.

Additional terms of the deal were not disclosed.

"Immunotherapy shows great promise for the treatment of specific types of metastatic cancer," Celsee CEO Kalyan Handique said in a statement. "This collaborative study will continue to validate the use of the Celsee Prep platform for detecting a wide range of surface biomarkers on rare cells in the blood, and substantiate the value of the platform for use in prognosis and therapeutic decision making."

IncellDx CEO Bruce Patterson added that his company's platform could potentially expand applications for Celsee's Prep platform from blood to rare-event detection in primary tumors.

The Scan

Genome Sequences Reveal Range Mutations in Induced Pluripotent Stem Cells

Researchers in Nature Genetics detect somatic mutation variation across iPSCs generated from blood or skin fibroblast cell sources, along with selection for BCOR gene mutations.

Researchers Reprogram Plant Roots With Synthetic Genetic Circuit Strategy

Root gene expression was altered with the help of genetic circuits built around a series of synthetic transcriptional regulators in the Nicotiana benthamiana plant in a Science paper.

Infectious Disease Tracking Study Compares Genome Sequencing Approaches

Researchers in BMC Genomics see advantages for capture-based Illumina sequencing and amplicon-based sequencing on the Nanopore instrument, depending on the situation or samples available.

LINE-1 Linked to Premature Aging Conditions

Researchers report in Science Translational Medicine that the accumulation of LINE-1 RNA contributes to premature aging conditions and that symptoms can be improved by targeting them.